Biotechnology AstraZeneca’s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Bristol Myers Squibb’s Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With Certain Mutation – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer – GSK (NYSE:GSK) Read more
Biotechnology AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology Pfizer-Acquired Seagen’s Adcetris Combo Therapy Extends Overall Survival Versus Placebo In Patients With Most Common Type Of Lymphoma – Pfizer (NYSE:PFE) Read more
Biotechnology Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead’s and Merck’s Combo Therapy – Merck & Co (NYSE:MRK), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more